Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 4 June 2020, after a week of increasing scientific concern and scrutiny, first The Lancet, then the New England Journal of Medicine, retracted studies that were based on inaccessible data. The studies have been extremely damaging to chloroquine and hydroxychloroquine COVID-19 clinical trials around the globe. MORU researchers played a key role in bringing this scandal to light, whose consequences continue to play out.

Composite image of many hydroxychloroquine articles

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines

Journal article

Arman BY. et al, (2026), International Journal of Pharmaceutics: X, 11, 100467 - 100467

Rickettsial seropositivity in Lao PDR smallholder livestock farms: Implications for animal and human health.

Journal article

Tawfik C. et al, (2026), One health (Amsterdam, Netherlands), 22

Neglected rickettsial diseases in Southeast Asia: Twenty-five years of progress in surveillance, diagnostics, and clinical research

Journal article

Blacksell SD. et al, (2026), PLOS Neglected Tropical Diseases, 20, e0014318 - e0014318

Genetic Evidence of Cross-Border Plasmodium vivax Spread in a Malaria Pre-elimination Region of South Asia

Conference paper

Rai A. et al, (2026), The Journal of Infectious Diseases

Reconsidering the clinical assessment of resistance to slowly eliminated antimalarial drugs in high-transmission settings

Journal article

White NJ. and Watson JA., (2026), The Lancet Infectious Diseases, 26, e240 - e247

Burden of diarrhoeal diseases among hospitalised patients in Thailand: a retrospective national database analysis (2014-2022).

Journal article

Srisaeng S. et al, (2026), The Lancet regional health. Southeast Asia, 48

Genetic evidence of cross-border Plasmodium vivax spread in a malaria pre-elimination region of South Asia.

Journal article

Rai A. et al, (2026), The Journal of infectious diseases

Methods for estimating the burden of acute tropical infectious diseases: A scoping review.

Journal article

Wang Q. et al, (2026), PLoS neglected tropical diseases, 20

Load More